Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies (Q46595207)
scientific article published on 11 July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies |
scientific article published on 11 July 2005 |
Statements
1 reference
Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies (English)
1 reference
Alex A Adjei
1 reference
Lorelei Hanson
1 reference
Joel Reid
1 reference
Laura Bruzek
1 reference
Jill Piens
1 reference
Patricia M Lorusso
1 reference
Mary Varterasian
1 reference
Shirish Gadgeel
1 reference
David Y Mitchell
1 reference
Pamela DeLuca
1 reference
Peggy Asbury
1 reference
Keri Van Becelaere
1 reference
Roman Herrera
1 reference
Judith Sebolt-Leopold
1 reference
Mark B Meyer
1 reference
11 July 2005
1 reference
23
1 reference
23
1 reference
5281-5293
1 reference